Blue Heron Gets New CEO; Genomic Health OKs ’07 Salaries for Brass; Proteopure Names Invitrogen Alumnus to Board; and Others | GenomeWeb
NEW YORK (GenomeWeb News) — Ambit Biosciences, a small-molecule kinase-development company, has appointed Kerry Kelly to the position of vice president and general counsel, the company said Tuesday. Kelly recently was associate general counsel for The Scripps Research Institute and before that she was head of corporate affairs for biotech company Sugen, which has since been acquired by Pfizer.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.